Brunangelo Falini
Impact in
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 128
- Acute Myeloid Leukemia Research 103
- Genetics 113
- Chronic Lymphocytic Leukemia Research 89
Brunangelo Falini
382 papers receiving 32.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Pathology and Forensic Medicine 15.5k
- Genetics 7.6k
- Hematology 7.3k
- Oncology 10.7k
- Immunology 7.8k
Countries citing papers authored by Brunangelo Falini
This map shows the geographic impact of Brunangelo Falini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunangelo Falini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunangelo Falini more than expected).
Fields of papers citing papers by Brunangelo Falini
This network shows the impact of papers produced by Brunangelo Falini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunangelo Falini. The network helps show where Brunangelo Falini may publish in the future.
Co-authors
The 25 scholars most cited alongside Brunangelo Falini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 9 | |
| 3 | 2022 | 22 | |
| 4 | 2022 | 22 | |
| 5 | 2022 | 6 | |
| 6 | 2018 | 195 | |
| 7 | 2017 | 28 | |
| 8 | 2013 | 20 | |
| 9 | 2012 | 97 | |
| 10 | 2010 | 171 | |
| 11 | 2009 | 62 | |
| 12 | Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. | 2004 | 21 |
| 13 | 2002 | 76 | |
| 14 | Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia | 1999 | 2 |
| 15 | The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive ALCL | 1998 | 5 |
| 16 | A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments] Hit paper breakdown → | 1994 | 4981 |
| 17 | PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. | 1993 | 257 |
| 18 | 1990 | 63 | |
| 19 | 1988 | 91 | |
| 20 | 1986 | 71 |
About Brunangelo Falini
Brunangelo Falini is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Immunology and Oncology, having authored 390 papers that have together received 32.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (167 papers), Acute Myeloid Leukemia Research (103 papers), Chronic Lymphocytic Leukemia Research (89 papers), Immune Cell Function and Interaction (40 papers), Viral-associated cancers and disorders (39 papers), Retinoids in leukemia and cellular processes (33 papers), Monoclonal and Polyclonal Antibodies Research (33 papers) and Acute Lymphoblastic Leukemia research (31 papers). The work is most often cited by research in Pathology and Forensic Medicine (15.5k citations), Genetics (7.6k citations), Hematology (7.3k citations), Oncology (10.7k citations) and Immunology (7.8k citations). Brunangelo Falini has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Georges Delsol, Maria Paola Martelli, H Stein, Stefano Pileri, K C Gatter, ML Cleary, Banks Pm, Chan Jk, NL Harris and Chris Peeters. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Haematologica and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.